High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies

OBJECTIVE: To describe the experience managing treatment-refractory immune-mediated necrotizing myopathies (IMNM) with high-dose cyclophosphamide (HiCy) therapy. METHODS: Five patients with severe refractory IMNM who were treated with HiCy without stem cell rescue were identified. Their medical reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Mecoli, Christopher A., Lahouti, Arash H., Brodsky, Robert A., Mammen, Andrew L., Christopher-Stine, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619913/
https://www.ncbi.nlm.nih.gov/pubmed/28975138
http://dx.doi.org/10.1212/NXI.0000000000000381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619913/
https://www.ncbi.nlm.nih.gov/pubmed/28975138
http://dx.doi.org/10.1212/NXI.0000000000000381

Ejemplares similares